Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study Using Precision Cell Immunotherapy Combined With Transcatheter Arterial Chemoembolization in Advanced Liver Cancer

NCT02862613 is registered in ClinicalTrials.gov with Shanghai International Medical Center as lead sponsor.

NCT NCT02862613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02862613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study Using Precision Cell Immunotherapy Combined With Transcatheter Arterial Chemoembolization in Advanced Liver Cancer
Lead sponsor
Shanghai International Medical Center
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 31, 2016
Completion date
August 31, 2018
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced liver cancer, precision cells, transcatheter arterial chemoembolization